Developing Resiliency and Exercise Using AI-based Messaging
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: DREAM.
- Who it may be relevant to
- Registry conditions: Diabetes Mellitus Type 2. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Developing Resiliency and Exercise Using AI-based Messaging: The DREAM Pilot Study
Overview
This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.
Detailed description
This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program. DREAM is an 8-week message-based program to promote physical activity and well-being in adults with type 2 diabetes. In DREAM, participants will complete twice weekly messaging sessions, in which they will set weekly physical activity goals and perform activities to enhance well-being. The primary outcome is feasibility (measured by number of messaging sessions successfully transmitted) and acceptability (measured by 0-10 utility ratings). Secondary outcomes include preliminary impact on physical activity and psychological and health-related outcomes.
Interventions
- Behavioral DREAM
Participants will engage in twice weekly messaging sessions and will work towards a physical activity goal each week for a total of eight weeks.
Primary outcome measures
- Delivery of messaging sessions (feasibility) [Time frame: Twice weekly over 8 weeks]
Secondary outcome measures (5)
- Utility of the DREAM program [Time frame: 8 weeks]
- Utility of messaging sessions [Time frame: 8 weeks]
- Change in overall physical activity (in steps/day) [Time frame: Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only)]
- Change in moderate to vigorous physical activity (MVPA; in mean minutes/day) [Time frame: Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only)]
- Change in positive affect (Positive and Negative Affect Schedule [PANAS] positive affect items) [Time frame: Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)]
Eligibility criteria
Inclusion criteria
- Type 2 diabetes diagnosis (A1c ≥6.5%, fasting glucose ≥126 mg/dL)
- Suboptimal physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item)
- Access to a smartphone (i.e., Android or iOS) or computer with access to the internet and an internet browser
Exclusion criteria
- An unrelated condition limiting physical activity
- Participation in any other programs focused on physical activity or well-being
- A cognitive disturbance precluding participation or informed consent
- Current pregnancy or plan to become pregnant in the next 16 weeks
- Inability to speak/write fluently in English
- Use of non-basal insulin
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Prevention
Study locations
United States · 1 center
- Massachusetts General Hospital — Boston
Identifiers
NCT: NCT07225283 · 2025P002706